Blog
26 May, 2020
On May 20, Clinical Trial Day is celebrated worldwide About 80% of the studies that are launched in Spain are driven by the pharmaceutical industry Spain […]
25 May, 2020
Source: www.immedicohospitalario.es Since 2018, Novo Nordisk Spain has increased the number of patients in clinical trials by 50%, as detailed by Fernando Fuentes, head of Clinical […]
22 May, 2020
Industrial property is “the main reason why there is such a solid base of innovation from which to work to find solutions,” says the director of […]
14 May, 2020
This chronic disease has an incidence of between 3 and 7% of the population in Spain, according to experts Treatments provide clear results in patients’ health […]
12 May, 2020
In just a few months, Spain has launched 64 clinical trials with potential anti-coronavirus drugs, ranking first in Europe and fourth in the world. The brutal […]
27 April, 2020
Farmaindustria participates in a Eupati webinar aimed at patients from all over Spain Explain how laboratories are working, in collaboration with researchers and hospitals, so that […]
21 April, 2020
Via: www.elglobal.es Clinical and industry experts carry out a decalogue with measures to strengthen the Spanish research system In recent years, Spain has positioned itself among […]
20 April, 2020
Via: www.immedicohospitalario.es Farmaindustria has collected in a document the measures that 120 experts from hospital centers and pharmaceutical companies propose to boost Spanish leadership and attract […]
18 March, 2020
Source: www.actasanitaria.com The Spanish Agency of Medicines and Health Products (AEMPS), as the competent national authority in the authorization of clinical trials, has proposed a series […]
9 March, 2020
The European employer of the innovative industry has its sights set on the roadmap of the Industrial Strategy for the sector, which will be published next […]
4 March, 2020
Source: www.expansion.com The pharmaceutical industry is positioned as a leading actor for the necessary evolution of the Spanish economy towards a productive model supported by innovation […]
24 February, 2020
Source: www.immedicohospitalario.es The clinical efficacy of this new diagnosed tool has been tested in five hospitals with clinical trials, which is a step towards personalized medicine […]
10 February, 2020
The expected return on investment in new medicines stands at 1.8%, the lowest point in the last 10 years, according to a Deloitte report On the […]
7 February, 2020
Source: www.immedicohospitalario.es The arrival of advanced therapies, such as CAR-T cells, immunotherapy or other targeted treatments and their incorporation into the assistance protocols are being able […]
6 February, 2020
Farmaindustria advocates strengthening the role of the Spanish Agency for Medicines and Health Products (Aemps) to maintain the competitiveness of our country in biomedical R&D The […]
5 February, 2020
The impulse to biomedical research in this area allows disease control for longer, increases survival and improves the quality of life of patients The Spanish Agency […]
28 January, 2020
They are essential to demonstrate the safety of medicines, but they also represent a significant cost savings in the health centers where they are carried out. […]
16 January, 2020
Source: www.actasanitaria.es Farmaindustria has reported that the Economic and Social Council (CES), a consultative body of the Government in socio-economic and labor matters, published a comprehensive […]
13 January, 2020
The European agency EMA gives green light to 30 new drugs and the US FDA, to 48 Hematology and oncology account for more than a third […]
10 January, 2020
Source: www.20minutos.es Our country is one of the best conditions to host biomedical and pharmaceutical research projects, both national and international. In 1886, scientists Oskar Minkowski […]
8 January, 2020
One in five clinical trials in Oncology in our country investigates this type of tumor, which causes 22,000 deaths per year The available treatments have tripled […]
11 December, 2019
Source: www.immedicohospitalario.es Such a high percentage of participation in clinical research studies has no one. The Vall d’Hebron Institute of Oncology (VHIO) is a research […]
27 November, 2019
The Maternal and Child Hospital of Malaga hosted on Wednesday a new edition of the day ‘Bringing science closer to schools. Drug research and development ’, […]
20 November, 2019
Meeting with hospital pharmacists to exchange knowledge and experience between industry and professionals to promote trials It was agreed to establish a mixed working group to […]
15 November, 2019
Source: www.epfia.eu Unlocking the mystery behind Alzheimer’s disease and dementia and improving care for people require new types of partnership. As we navigate uncertain waters, we […]
11 November, 2019
The number of new treatments available against rare pathologies has multiplied by 20 in Europe since 2000 The industry insists on collaboration with governments and health […]
7 November, 2019
It is one of the keys that explain why Spain has become one of the countries in Europe with better conditions to develop clinical trials of […]
5 November, 2019
Experts from the Weber Foundation and Farmaindustria clear some doubts about drug spending and analyze research challenges. Source: www.farmaindustria.es The pharmaceutical sector is high risk; For […]
18 October, 2019
To the suffering of patients and relatives there are costs that in the European Union equal 4% of the GDP of the member countries This Thursday […]
16 October, 2019
Farmaindustria participates in Santiago de Compostela in the II National Meeting of the Spanish Network of Pediatric Clinical Trials Source: www.farmaindustria.es The research and development of […]
13 May, 2024
Recruitment forecasts for innovative pharmaceutical companies for the coming years exceed 10,000 new jobs for the under-30s. The website offers practical information about the sector and […]
30 April, 2024
Funcas and Farmaindustria held a conference on ‘The economic regulation of the pharmaceutical industry. Current situation and future prospects in Spain’, which was attended by more […]
24 April, 2024
Spain is at the forefront of research. Experts discuss the potential of new medicines at a forum organised by EL PAÍS and Farmaindustria. Elpais.com In the […]
22 April, 2024
DemócrataPRO brings together the Health Commission to debate on the reform of the law on medicines On 21 March, DemócrataPro brought together the spokespersons of the […]
3 April, 2024
The Spanish Technological Platform for Innovative Medicines, led by Farmaindustria, has been promoting public-private collaboration projects in clinical and pre-clinical research since 2005. “Spain currently occupies […]
2 April, 2024
Human papillomavirus is responsible for 95% of cervical tumours. Since 2006, several vaccines have been licensed that can prevent most cases. In Spain, the autonomous communities […]
19 March, 2024
The health sector, essential for the well-being of the population and an economic engine for society
fundacionidis.com The ecosystem of the private healthcare sector transcends the field of healthcare and has an impact on society and on the productive sectors of the […]
7 March, 2024
There are 146 orphan drugs approved by the European Medicines Agency. Spain has only 81 in its catalogue. It has rejected funding for 25 and is […]
5 March, 2024
Research into new drugs for rare diseases has multiplied in recent years. In Spain, industry drives 90% of clinical trials for this type of disease. One […]
13 February, 2024
In a press release, the Andalusian Regional Government highlights the joint commitment of both entities to continue advancing in the promotion of R&D&I, following the meeting […]
8 February, 2024
Of the 1,944 clinical trials authorised in the European Union through the new European Information System, Spanish centres participated in 845, or 43% of the total. […]
6 February, 2024
The European Medicines Agency has thus identified nine oncology approvals for 2023. The arrival of new treatments is directly linked to the pharmaceutical industry’s commitment to […]
